First-in-Human Trial of BCMA-CD19 Compound CAR (cCAR) in Desensitization of Donor-Specific Anti-HLA Antibodies (DSAs) in Haploidentical Stem Cell Transplant Recipients
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Fang Liu, Yu MA, Yecheng LI, Kevin G. Pinz, Xiao Wang, Masayuki Wada, Yupo Ma
Institution: Chengdu Military General Hospital
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405039680